Detalhe da pesquisa
1.
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
N Engl J Med
; 378(22): 2078-2092, 2018 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29658856
2.
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.
Lancet Oncol
; 17(11): 1497-1508, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27745820
3.
Slow-release granisetron (APF530) versus palonosetron for chemotherapy-induced nausea/vomiting: analysis by American Society of Clinical Oncology emetogenicity criteria.
Future Oncol
; 11(18): 2541-51, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26289588
4.
Comparison of an extended-release formulation of granisetron (APF530) versus palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately or highly emetogenic chemotherapy: results of a prospective, randomized, double-blind, noninferiority phase 3 trial.
Support Care Cancer
; 23(3): 723-32, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25179689
5.
The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC "Neutropenia, Infection and Myelosuppression" Study Group during the MASCC annual meeting held in Berlin on 27-29 June 2013.
Support Care Cancer
; 24(7): 2819-26, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27098065
6.
Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trials.
Lung Cancer
; 63(1): 50-7, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18565615
7.
Pembrolizumab in Combination With Erlotinib or Gefitinib as First-Line Therapy for Advanced NSCLC With Sensitizing EGFR Mutation.
J Thorac Oncol
; 14(3): 553-559, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30529597
8.
Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non-small-cell lung cancer: KEYNOTE-021 cohorts D and H.
Lung Cancer
; 130: 59-66, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30885353
9.
Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop.
J Immunother Cancer
; 7(1): 131, 2019 05 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31113486
10.
Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop.
J Immunother Cancer
; 7(1): 167, 2019 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31272507
11.
The MASCC Neutropenia, Infection and Myelosuppression Study Group evaluates recent new concepts for the use of granulocyte colony-stimulating factors for the prevention of febrile neutropenia.
Support Care Cancer
; 21(6): 1793-5, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23525960
12.
Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non-small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study.
Lung Cancer
; 125: 273-281, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30429032
13.
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy.
J Clin Oncol
; 23(12): 2822-30, 2005 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-15837996
14.
Supportive care in lung cancer.
Hematol Oncol Clin North Am
; 19(2): 369-87, vii, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15833411
15.
A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell cycle inhibitor.
Clin Cancer Res
; 10(14): 4680-7, 2004 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15269140
16.
Carcinoma of the lung and metastatic disease of the central nervous system.
Am J Respir Crit Care Med
; 178(10): 1090; author reply 1090, 2008 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18987348
17.
Molecular testing in lung cancer: fine-needle aspiration specimen adequacy and test prioritization prior to the CAP/IASLC/AMP Molecular Testing Guideline publication.
Cancer Cytopathol
; 122(6): 454-8, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24723383
18.
Progress in the Control of Chemotherapy-Induced Emesis: New Agents and New Studies.
J Oncol Pract
; 5(3): 130-133, 2009 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29452040
19.
Diagnosis and management of hyponatremia in cancer patients.
Support Care Cancer
; 15(12): 1341-7, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17701059
20.
Oncologists as primary palliative care providers.
J Clin Oncol
; 30(22): 2801-2; author reply 2802, 2012 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22753912